Company / Operating Margin
TG Therapeutics, Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
20.0%
FY2025
5-year range
-7839.0% / 20.0%
FY2021-FY2025
Trend
+57.1%
vs FY2024
Sector context
#27 of 136
Health Care
What the data says
TG Therapeutics, Inc.'s operating margin of 20.0% is higher than 80% of companies in the Health Care sector (FY2025). Operating Margin has increased for 3 consecutive years, from -7839.0% in FY2022 to 20.0% in FY2025.
Based on SEC 10-K filings.
20.0% in FY2025 with a 5-year CAGR of +180016.1%. Top quartile in the Health Care sector.
Improved from 8.8% to 20.0% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +7859.0pp
- 5-Year Change
- +180016.1pp
- 10-Year Change
- -
Sector benchmark
+102.6% above sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 57.1% year-over-year.
- Currently 798.9pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 20.0% | +57.1% |
| FY2024 | 12.7% | +44.3% |
| FY2023 | 8.8% | +100.1% |
| FY2022 | -7839.0% | -52.1% |
| FY2021 | -5154.3% | +97.1% |
| FY2020 | -179996.0% | -130.5% |
| FY2019 | -78100.0% | +31.9% |
| FY2018 | -114736.8% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026